D.A. Davidson & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $470K | Sell |
1,553
-620
| -29% | -$188K | ﹤0.01% | 1076 |
|
2025
Q1 | $720K | Buy |
2,173
+1,458
| +204% | +$483K | 0.01% | 893 |
|
2024
Q4 | $221K | Buy |
+715
| New | +$221K | ﹤0.01% | 1303 |
|
2024
Q3 | – | Sell |
-715
| Closed | -$200K | – | 1404 |
|
2024
Q2 | $200K | Buy |
+715
| New | +$200K | ﹤0.01% | 1284 |
|
2023
Q1 | – | Sell |
-720
| Closed | -$209K | – | 1362 |
|
2022
Q4 | $209K | Buy |
+720
| New | +$209K | ﹤0.01% | 1178 |
|
2019
Q1 | – | Sell |
-1,775
| Closed | -$200K | – | 1157 |
|
2018
Q4 | $200K | Sell |
1,775
-160
| -8% | -$18K | ﹤0.01% | 994 |
|
2018
Q3 | $414K | Sell |
1,935
-5
| -0.3% | -$1.07K | 0.01% | 786 |
|
2018
Q2 | $543K | Sell |
1,940
-995
| -34% | -$278K | 0.01% | 673 |
|
2018
Q1 | $343K | Sell |
2,935
-865
| -23% | -$101K | 0.01% | 823 |
|
2017
Q4 | $349K | Buy |
+3,800
| New | +$349K | 0.01% | 786 |
|
2017
Q3 | – | Sell |
-3,950
| Closed | -$64K | – | 1618 |
|
2017
Q2 | $64K | Sell |
3,950
-1,200
| -23% | -$19.4K | ﹤0.01% | 1440 |
|
2017
Q1 | $79K | Buy |
5,150
+4,650
| +930% | +$71.3K | ﹤0.01% | 1340 |
|
2016
Q4 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 2185 |
|